Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoj M Pillai

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Molecular Cancer Research : MCR|September 16, 2017
Alternative Polyadenylation of <i>PRELID1</i> Regulates Mitochondrial ROS Signaling and Cancer OutcomesAustin E Gillen, Heather M Brechbuhl, Tomomi M Yamamoto, et al.
Molecular and Cellular Biology|November 1, 2016
E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated ErythroblastsKelsey L Swartz, Scott N Wood, Tushar Murthy, et al.
Breast Cancer Research and Treatment|June 8, 2014
HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancerManoj M Pillai, Austin E Gillen, Tomomi M Yamamoto, et al.
Nucleic Acids Research|November 22, 2018
Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1)Abhishek K Gupta, Tushar Murthy, Kiran V Paul, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant CancersPrajwal C Boddu, Rahul Roy, Stephen Hutter, et al.
The Journal of Biological Chemistry|April 24, 2019
Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progressionJung-Sik Kim, Xiaoyuan He, Jie Liu, et al.
Cancers|September 11, 2020
Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer CellsMichal Marczyk, Gauri A Patwardhan, Jun Zhao, et al.
NAR Cancer|May 9, 2022
Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2)Shilpita Karmakar, Oscar Ramirez, Kiran V Paul, et al.
Leukemia & Lymphoma|May 5, 2020
Clinical outcomes and characteristics of patients with <i>TP53</i>-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experienceJan Philipp Bewersdorf, Rory M Shallis, Lohith Gowda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to EstrogenHeather M Brechbuhl, Jessica Finlay-Schultz, Tomomi M Yamamoto, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Molecular Cancer Research : MCR|September 16, 2017
Alternative Polyadenylation of <i>PRELID1</i> Regulates Mitochondrial ROS Signaling and Cancer OutcomesAustin E Gillen, Heather M Brechbuhl, Tomomi M Yamamoto, et al.
Molecular and Cellular Biology|November 1, 2016
E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated ErythroblastsKelsey L Swartz, Scott N Wood, Tushar Murthy, et al.
Breast Cancer Research and Treatment|June 8, 2014
HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancerManoj M Pillai, Austin E Gillen, Tomomi M Yamamoto, et al.
Nucleic Acids Research|November 22, 2018
Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1)Abhishek K Gupta, Tushar Murthy, Kiran V Paul, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant CancersPrajwal C Boddu, Rahul Roy, Stephen Hutter, et al.
The Journal of Biological Chemistry|April 24, 2019
Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progressionJung-Sik Kim, Xiaoyuan He, Jie Liu, et al.
Cancers|September 11, 2020
Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer CellsMichal Marczyk, Gauri A Patwardhan, Jun Zhao, et al.
NAR Cancer|May 9, 2022
Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2)Shilpita Karmakar, Oscar Ramirez, Kiran V Paul, et al.
Leukemia & Lymphoma|May 5, 2020
Clinical outcomes and characteristics of patients with <i>TP53</i>-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experienceJan Philipp Bewersdorf, Rory M Shallis, Lohith Gowda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to EstrogenHeather M Brechbuhl, Jessica Finlay-Schultz, Tomomi M Yamamoto, et al.
Pageof 3